0.01
-3.70%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Encompass Compliance
Its shares trade under the ticker ENCC. It has been listed since 13 March 2000. In the fiscal year to 31 December 2019, it reported revenue of $367,399 and a net loss of $290,798. At that date it held total assets of $16,146 and shareholders' equity of −$291,764.
Encompass Compliance Corp. engages in the provision of workplace drug and alcohol testing compliance services. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2000-03-13. The firm offers an annual subscription service, which maintains compliance and updates employers on the impact of the law, to their workplace. Its services include statutes, regulations, court decisions and the Drug Testing Compliance Matrix, which provides the guidance for managing the rules that apply. The company focuses on Medical Marijuana, Opiates, Synthetics, as well as other drugs and alcohol usage in the workplace. The firm also offers training modules, consulting on the implementation of this service, and training tools, as well as Claims defense services to its customers. Its solutions provide organizations with up-to-date policies, a resource center and real-time monitoring for drug and alcohol testing orders. The firm offers Risk Shield, which allows employers to create a core drug and alcohol policy and accounts for all regulations.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Professional Services
- Listed since
- 13 Mar 2000
- Website
- encompinc.com ↗
Leadership
Pay as last reported
- Michael RothChairman of the Board, Chief Executive Officer
- Scott HansburyVice Chairman of the Board, Chief Operating Officer, Executive Vice President
- Chris DiazChief Creative Officer
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Encompass Compliance Corp provides annual subscription services for workplace drug testing compliance updates.
- The company offers Risk Shield for creating core drug and alcohol policies covering all regulations.
- Encompass Compliance Corp's Drug Testing Compliance Matrix guides employers on applicable rules.
Weaknesses
- The company's focus on Medical Marijuana, Opiates, and Synthetics may limit broader market appeal.
- Encompass Compliance Corp's services are limited to workplace drug and alcohol testing compliance.
- The firm's annual subscription model may not attract all potential clients seeking one-time solutions.
Opportunities
- Expanding into new markets like the US healthcare sector for drug testing services.
- Increasing demand for workplace compliance services in the US industrial sector.
- Growing need for real-time monitoring tools in the professional services industry.
Threats
- Regulatory changes in the US could impact the company's compliance services.
- Competition from other professional services firms in the US market.
- Economic downturns affecting business spending on workplace compliance services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.